The opioid epidemic underscores the importance of healthcare providers integrating a multimodal approach to safe and effective pain management. Doing so requires not only comprehensive assessment of patients, but the consideration of non-opioid medications, selected based on the severity of pain and injury. The Orthopedic Trauma Association recently released their Clinical Practice Guidelines including recommendations for pain medication strategies, cognitive strategies, physical modalities, and system tools, all of which are imperative when addressing pain management.
In part 2 of this 3-part series, expert faculty focus on the four-step approach that follows the SOAP (Subjective-Objective-Assessment-Plan) approach to pain management, as well as principles of communication with patients experiencing pain in order to help clinicians appropriately prescribe the best therapy for pain management in each patient.
At the end of this CME/CE activity, participants should be able to:
The following learning objectives pertain only to those requesting CNE or CPE credit:
Supported by an educational grant from Johnson & Johnson.
Physicians, dentists, physician assistants, nurse practitioners, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Gold has no disclosures to report.
Dr. Abubaker has no disclosures to report.
Mr. Alden has no disclosures to report.
Ms. Judd reports that she is on the speakers bureau for Alkermes; Neurocrine Biosciences, Inc.; Otsuka America Pharmaceutical, Inc.; Sunovion Pharmaceuticals Inc. She is on the advisory board for ACADIA Pharmaceuticals Inc.; Neurocrine Biosciences, Inc.
Dr. Mir reports that he is a consultant for OrthoGrid Systems, Inc.; Smith & Nephew; StabilizOrtho; Trice Medical; Zimmer Biomet.
Dr. Schmidt has no disclosures to report.
Dr. Stanos reports that he receives research support from Grunenthal and is a consultant for SCILEX Pharmaceuticals, Inc.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.